Investor

Laprophan S.A

Compiled from public sources

Laprophan SA is a Casablanca-headquartered pharmaceutical company operating as a prominent Corporate Strategic Investor across Africa and international healthcare markets. Founded in 1949 by Abderrahim Bennis, the pioneering enterprise is structurally backed by an institutional private equity consortium led by Mediterrania Capital Partners alongside European development finance institutions (DEG, FMO, and Proparco). The firm executes an aggressive, industry-focused buy-and-build investment strategy, deploying corporate balance-sheet capital and strategic financing rounds to acquire controlling equity stakes in complementary pharmaceutical companies, manufacturing facilities, and speciality formulation laboratories. By integrating cross-border platforms—such as its acquisitions of Amanys Pharma and Switzerland-based Rivopharm—the firm operates as a strategic general partner transforming local manufacturing networks into an international B2B pharmaceutical platform spanning Europe, Africa, and the Middle East.